Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21
This work was supported by the National Natural Science Foundation of China (U23A20501, 82404816), the key research and development plan projects of Heilongjiang Province (2022ZX02C04), the Guangdong Basic and Applied Basic Research Found Project (2023A1515110703), the Traditional Chinese Medicine Bureau Of Guangdong Province (20254061), the State Key Laboratory of Dampness Syndrome of Chinese Medicine (SZ2021ZZ49, SZ2022KF16), the Second Affiliated Hospital of Guangzhou University of Chinese Medicine(YN2024GZRPY017)
Tirzepatide: A dual GIP/GLP-1 receptor agonist administered once weekly
Units on a U-100 syringe: 0.045 mL 100 = 4.5 units (round to the ~45 unit mark on the barrel)
To view a copy of this license, visit About this article Cite this article Fujisawa, K., Takami, T., Matsuzaki, A